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Shigella sonnei increasingly dominates the international epidemiological landscape of shi-
gellosis. Treatment options for S. sonnei are dwindling due to resistance to several key
antimicrobials, including the fluoroquinolones. Here we analyse nearly 400 S. sonnei whole
genome sequences from both endemic and non-endemic regions to delineate the evolu-
tionary history of the recently emergent fluoroquinolone-resistant S. sonnei. We reaffirm that
extant resistant organisms belong to a single clonal expansion event. Our results indicate that
sequential accumulation of defining mutations (gyrA-S83L, parC-S80I, and gyrA-D87G) led to
the emergence of the fluoroquinolone-resistant S. sonnei population around 2007 in South
Asia. This clone was then transmitted globally, resulting in establishments in Southeast Asia
and Europe. Mutation analysis suggests that the clone became dominant through enhanced
adaptation to oxidative stress. Experimental evolution reveals that under fluoroquinolone
exposure in vitro, resistant S. sonnei develops further intolerance to the antimicrobial while
the susceptible counterpart fails to attain complete resistance.
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S higella is ranked among the leading causes of diarrhoealdisease in children under five years of age1,2, and causes~160,000 deaths per year across all age groups globally.
The Shigella genus is comprised of four serogroups (S. dysenter-
iae, S. boydii, S. flexneri and S. sonnei); however, the majority of
Shigella infections are associated with organisms belonging to S.
flexneri and S. sonnei. S. flexneri has traditionally been associated
with disease in developing countries, while S. sonnei has been
associated with more developed settings. This trend, however, is
changing, with S. sonnei prevailing in modernising countries,
particularly in Asia3,4.
The principal virulence determinant of Shigella is the type III
secretion system encoded by a large virulence plasmid, which
enables the pathogen to invade the colonic mucosa and kill
resident macrophages, triggering inflammatory responses and
causing damage to the intestinal epithelium5. It is this damage
that causes the distinctive symptom of bloody/mucoid diarrhoea
in shigellosis. Although the majority of Shigella infections are self-
limiting, shigellosis can be severe if left unattended6. Routine
treatment relies on antimicrobials to accelerate recovery, prevent
complications, and reduce onward transmission. Current World
Health Organization (WHO) guidelines recommend the use of
ciprofloxacin, a fluoroquinolone (FQ), for the treatment of shi-
gellosis6. Fluoroquinolones are a safe, well tolerated, highly
effective antimicrobial class with broad-spectrum activity and are
highly efficacious for treating Shigella-associated diarrhoea.
However, the widespread use of fluoroquinolones has led to
increasing resistance in many Shigella species, raising questions
about their utility7. Indeed, FQ-resistant (FQr) Shigella have been
placed on the global priority list for pathogens requiring urgent
antimicrobial development8. The U.S. Centers for Disease Con-
trol and Prevention (CDC) now recommend that fluor-
oquinolones should not be prescribed for infections caused by
Shigella with a minimum inhibitory concentration (MIC) of
>0.12 μg/mL against ciprofloxacin (https://emergency.cdc.gov/
han/han00401.asp). This threshold is considerably lower than
the currently defined 1 μg/mL breakpoint for ciprofloxacin
resistance defined by the European Committee on Antimicrobial
Susceptibility Testing (EUCAST) (http://www.eucast.org/
clinical_breakpoints/).
We recently demonstrated that the extant FQr S. sonnei
population, now reported worldwide, likely emerged from a single
common ancestor in South Asia, the descendants of which moved
across Asia prior to intercontinental dissemination9. Despite the
significance of these findings, our inferences were derived from
limited sampling, consisting of genome sequences generated from
70 FQr S. sonnei isolates. Here, we include >300 globally sourced
FQr S. sonnei to understand the life history of this looming public
health threat, particularly within the phylogenetic context pro-
vided by contemporary South Asian isolates. This extensive col-
lection (~400 organisms over a timespan of 20 years) allows us to
delineate how this FQr S. sonnei clone evolved both within and
outside of South Asia, thus revealing in detail its evolutionary
history, global epidemiology, pangenome repertoire, and adaptive
signatures. Additionally, we further evaluate the evolutionary
trajectories of FQr and FQ-susceptible (FQs) S. sonnei under
experimental conditions, showing that the two variants exhibit
differing patterns of mutation accumulation.
Results
The clonal expansion of FQr S. sonnei. Our previous analysis of
70 representative FQr S. sonnei suggested that they emerged as a
single clone (nested within CenAsiaIII) in South Asia and sub-
sequently radiated internationally9. Here, we utilised a collection
of 411 internationally isolated S. sonnei, including 265
contemporary isolates sequenced for the purpose of this study
(Table 1). Hypothesising that South Asia was the most likely
origin of FQr S. sonnei, isolates were preferentially selected from
collaborating institutes if they originated from this region or
showed reduced susceptibility to ciprofloxacin (intermediate to
full resistance). This approach resulted in the over-representation
of South Asian S. sonnei (306/411; from India, Bhutan, Nepal,
Bangladesh, Pakistan, and Sri Lanka), spanning a period of 16
years (1999–2014). Within this collection, 76% (313/411) of the
isolates exhibited phenotypic resistance to ciprofloxacin (defined
as FQr) and were isolated as early as 2008. These emphases
allowed us to reconstruct the evolutionary history of FQr S.
sonnei with fine granularity. Preliminary phylogenetic recon-
struction showed that 11 isolates clustered outside the CenAsiaIII
clade, and these were removed from further phylogenetic ana-
lyses; five of these exhibited reduced susceptibility to cipro-
floxacin (MIC ranges 0.094–0.125 μg/mL).
Maximum likelihood (ML) phylogenetic reconstruction of 395
CenAsiaIII S. sonnei verified that almost all FQr organisms
(98.7%; 307/311) belonged to a single clone, with FQr conferred
by the classical sequential mutations in the quinolone resistance
determining region (QRDR): gyrA-S83L, parC-S80I and gyrA-
D87G (Fig. 1). These data confirmed that the current global
burden of FQr S. sonnei was strongly associated with a single
clonal expansion event. We observed a single FQr isolate
(Sh_sonnei_1446) that was a sister taxon to the major FQr clone,
sharing with it the gyrA-S83L and parC-S80I mutations, but
harbouring a distinct gyrA codon 87 mutation (gyrA-D87N). This
observation highlights the presence of other non-sampled FQr S.
sonnei isolates with differing secondary gyrA mutations, although
these appeared to be present at lower frequencies. In addition,
QRDR single mutants, each carrying a mutation in either gyrA
codon 83 or 87, appear to have arisen on at least six independent
occasions, leading to an initial reduced susceptibility to FQ (i.e.
incomplete resistance). Plasmid-mediated quinolone resistance
(PMQR) genes were uncommon, with qnrS1 found in two S.
sonnei (already harbouring the aforementioned triple mutation)
and no organisms possessing aac(6′)-lb-cr, qepA, or oxqAB.
Bayesian hierarchical clustering using core SNPs segregated the
CenAsiaIII clade into two distinct subpopulations, which we refer
to herein as Pop1 (mainly FQs; n= 83) and Pop2 (mainly FQr;
n= 312) (Supplementary Fig. 1). To reconstruct the evolutionary
history of the CenAsiaIII clade, we selected 72 isolates from each
of these two subpopulations and subjected them to Bayesian
phylogenetic analysis using BEAST. The mean nucleotide
substitution rate for the entire CenAsiaIII clade was estimated
to be 7.34 × 10−7 substitutions per site per year [95% highest
posterior density (HPD): 6.77 × 10−7 to 7.91 × 10−7], and we
infer that this clade likely emerged in the late 1980s (95% HPD:
1986–1990) (Fig. 2). This timeline is in accordance with previous
estimates from an analysis of the global evolutionary history of
S. sonnei10. The tree topology shows that Pop2 emerged from
within Pop1 (Fig. 2), and allowed us to estimate the timing of
stepwise QRDR mutation accumulation leading to the formation
of the major FQr clone.
Within Pop1, two lineage-defining gyrA mutations likely arose
independently within the mid-1990s, forming two major
subclades with quinolone (i.e. nalidixic acid) resistance: gyrA-
S83L in ~1995 (95% HPD: 1994.6–1997) and gyrA-D87Y in
~1996 (95% HPD: 1995.4–1998) (Fig. 2). The gyrA-S83L lineage
later gave rise to Pop2 and its dominant FQr subclade, following
the acquisition of parC-S80I between 2001 (95% HPD:
2000.5–2002.6) and 2005 (95% HPD: 2003.9–2006.4), and then
gyrA-D87G around 2007 (95% HPD: 2006.5–2007.6) (Fig. 2).
Bayesian phylogenetic analysis of the Pop2 subclade yielded
similar estimates in terms of the timeline of emergence of the
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major FQr clone. We separately conducted a BEAST analysis of
only this clone to examine its demographic history, inferring that
its population expanded rapidly after emergence in 2007, peaked
around 2008, and maintained a relatively constant size thereafter
(Supplementary Fig. 2).
Geographical dissemination of FQr S. sonnei from South Asia.
It is apparent in the ML phylogeny of all CenAsiaIII isolates that
South Asian isolates are diverse and deep branching across the
tree, consistent with an origin in this region (Fig. 1). To test this
quantitatively, we generated 1000 geographically down-sampled
phylogenies (from the aforementioned ML phylogeny) to reduce
sampling location bias (with equal representation of South Asia,
Europe, Africa, and Southeast/East Asia) and employed stochastic
mapping to evaluate the most probable geographical origin of the
CenAsiaIII clade (see Methods). These analyses supported South
Asia as the primary hub for intercontinental spread, with Cen-
AsiaIII S. sonnei being transmitted from this region to Africa,
Southeast/East Asia, and Europe on an average of 7.65 (IQR:
5–9), 3.47 (IQR: 2–5), and 3.8 (IQR: 3–4) independent events per
tree, respectively (summarised across the 966 subsampled phy-
logenies with successful stochastic mapping) (Fig. 3a). In addi-
tion, approximately half of the evolutionary time inferred across
the entire CenAsiaIII phylogeny was predicted to be in South
Asia, providing further evidence that the clade has been
circulating and evolving principally in this region (Fig. 3b).
Analyses of tip-location randomised phylogenies produced sig-
nificantly different inferences compared to those estimated from
the true ML phylogeny (Supplementary Fig. 3). In particular, the
evolutionary time spent in South Asia was significantly higher in
the true ML phylogeny, compared to all randomised datasets (p <
0.05 in 10/10 comparisons, ANOVA-Tukey’s test [F value: 186.3,
df: 10]). These results provide strong evidence that our conclu-
sions concerning the South Asian origin of the clade result from
inherent phylogeographic signal in the data, rather than over-
representation of South Asian isolates in this collection.
Two distinct regional diversification events from South Asia
are evident within the FQr clone, with one being introduced into
Southeast Asia (Vietnam, Thailand, and Cambodia; light yellow
box in Fig. 2) by 2010 (95% HPD: 2010–2011.7), and another
instigating sustained transmission within Europe (Ireland, Italy,
Germany, and Spain; light orange box in Fig. 2) from 2009 (95%
HPD: 2009–2010.2). Notably, despite a dense sampling strategy,
there was no immediate outgroup for the Southeast Asia subclone
(Fig. 2). Detailed examination identified 18 chromosomally
dispersed mutations specific to this subclone, confirming its
divergence from the trunk of the phylogeny. We speculate that
this long branch may be the result of a recent population
bottleneck or intermediate unsampled isolates that were vital to
transition from South Asia to Southeast Asia. Within this
subclone was a number of organisms isolated from Australian
gyrA S83L pHUSEC41-1
pHUSEC41-1 &
pFORC11.2 recombinant
Other pHUSEC41-1
variants
pKHSB1
pSWeltevreden2
Other Incl1
blaCTX-M
mphA
CTX-M-15
CTX-M-14
CTX-M-55
Present
0.01 substitutions per site
IncX4
pHUSE41-1 & pEB1
recombinant
QRDR mutations Inc-type plasmid
Ciprofloxacin
World region
Resistant
Susceptible
South Asia
America
Middle East
Africa
Southeast Asia
East Asia
Europe
parC S80I
gyrA D87G
gyrA D87Y
gyrA D87N
gyrA D87A
IncK
IncX1
Fig. 1 The phylogenetic structure of CenAsiaIII Shigella sonnei. The figure displays the maximum likelihood phylogeny of 395 S. sonnei sequences belonging
to the CenAsiaIII clade. The tree is rooted on the most closely related sequence from the S. sonnei global sequencing study. The branch colour scheme
indicates bootstrap support for the corresponding branch, ranging from low to high (red to black). The shading covered on the phylogeny indicates taxa
harbouring quinolone resistance determining region (QRDR) mutations (see key). The orange diamond indicates the internal node leading to the major
fluoroquinolone-resistant (FQr) clone. The magenta triangle denotes the position of taxon 2012–02037, which was subjected to long-read sequencing (see
Methods). The rings show the associated information for each taxon, from the innermost to the outermost in the following order: (1) susceptibility testing
for ciprofloxacin (black: resistance; brown: susceptible); (2) original geographical source; (3) presence of different plasmids; (4) presence of ESBL blaCTX-M
genes; (5) presence of mphA. The horizontal scale bar indicates the number of nucleotide substitutions per site
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and European patients (12 occasions), thus highlighting the
association between international travel and secondary introduc-
tions to shigellosis non-endemic populations. The second
subclone, comprised mainly of organisms from Europe, shared
its most closely related outgroups with sequences from South
Asia, again suggesting likely introduction from this region (Figs. 1
and 2).
Multi-drug resistance in FQr S. sonnei. Aside from FQ resis-
tance, it was important to characterise the entire antimicrobial
resistance gene (ARG) content of organisms within the Cen-
AsiaIII population. Genes encoding resistance to previous first-
line antimicrobials for treating shigellosis were commonplace
within the clade, as observed previously10,11. These included the
small spA plasmid, conferring resistance to streptomycin (strAB),
tetracycline (tetRA), and sulphonamide (sul2), and a class II
integron conferring resistance to trimethoprim (dfrA1). Other
notable ARGs included those belonging to the extended spectrum
beta-lactamase (ESBL) blaCTX-M family; these were particularly
enriched in the Southeast Asia subclone (Fig.1), but only spor-
adically detected among the South Asia isolates. Three blaCTX-M
variants were carried on different plasmid structures; these were
acquired independently in Southeast Asia, specifically Vietnam
(Fig. 1, Supplementary Fig. 1). While blaCTX-M-55 mainly co-
existed with an IncB-O plasmid (recombinant of pEB1 and
pHUSEC41-1) in five Vietnamese isolates, the blaCTX-M-15 variant
was co-transferred with the IncI1 plasmid pKHSB1 and clonally
maintained in six additional Vietnamese isolates. Notably,
pKHSB1 and its blaCTX-M-15 have been the adaptive signature of
the indigenous Global III-clade S. sonnei population in Ho Chi
Minh City since 200612. This observation highlights the
Region
Africa
America
East Asia
Europe
South Asia
Southeast Asia
phoE, yeaK, uxaC,
ybdR, citF, yqiH
yaiU, yddA
fliCAZY
ycbO
flhC
ybeM
gyrA
S83L
gyrA
D87Y
parC
S80I
gyrA
D87G
Pop2
Pop1
1988 1992 1996 2000
Time
2004 2008 2012 2015
ecpD
Fig. 2 Temporal phylogenetic reconstruction of CenAsiaIII Shigella sonnei overlaid with pseudogenes. A maximum clade credibility phylogenetic
reconstruction of 144 CenAsiaIII S. sonnei is shown. Asterisks indicate posterior probability support >80% on major internal nodes. The red diamond
indicates the internal node leading to the major fluoroquinolone-resistant (FQr) clone. Grey arrows designate branches on which certain quinolone
resistance determining region (QRDR) mutations occurred. Lineage-defining pseudogenes and gene loss events are indicated above corresponding
branches. Tip colours show the original geographical isolation regions of taxa (see key). The light orange and light yellow boxes highlight the European and
Southeast Asian clonal expansions of CenAsiaIII, respectively. The dark dashed line separates the two populations (Pop1 and Pop2) in CenAsiaIII, defined
by Bayesian hierarchical clustering
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promiscuity of this specific plasmid background among different
S. sonnei lineages circulating in the same location. We addition-
ally recorded four independent instances of mphA (conferring
azithromycin resistance) acquisition within this Vietnamese
expansion, two of which were co-transferred with blaCTX-M genes
(Fig. 1), and have characterised the genetic details of these pan-
resistant S. sonnei elsewhere13. Significantly, this combination of
mutations and ARG renders these organisms resistant to all
current first-line antimicrobials used for dysentery treatment (FQ,
3rd generation cephalosporins, and macrolides).
We catalogued the presence of major plasmids in all
CenAsiaIII S. sonnei and found that IncB-O and IncI1 plasmids
were the most common (Fig. 1). Detailed manual plasmid
comparisons revealed that all IncB-O plasmids were closely
related to pHUSEC41-1 or recombinant variants (nucleotide
identity >98%, coverage >80%). These plasmids exhibited
associations with specific geographical locations (Supplementary
Data 2). Specifically, pHUSEC41-1 was found to circulate
primarily in Europe, while the pHUSEC41-1-pEB1 and
pHUSEC41-1-pFORC11.2 recombinants were found in Vietnam
and Bhutan, respectively (Fig. 1, Supplementary Fig. 1). Notably,
plasmids of the pHUSEC41-1 family were favourably maintained
in the FQr S. sonnei following local introductions, despite
geographical discrepancy. The IncI1 plasmids, present in 42 S.
sonnei isolates, displayed greater diversity than the IncB-O
plasmids with respect to their origins. These IncI1 plasmid
structures were similar to IncI1 plasmid structures found in
GenBank for Salmonella spp. (n= 14 plasmids), E. coli (n= 13),
S. sonnei (n= 11), and K. pneumoniae (n= 3) (Supplementary
Data 2). Most notably, two Vietnamese subpopulations separately
harboured pKHSB1 (S. sonnei) and pSWeltevreden2 (originally
described in Salmonella Weltevreden) (Fig. 1, Supplementary
Fig. 1). These data demonstrate that once FQr S. sonnei enters a
new location, it has access to a wide gene pool shared among the
indigenous Enterobacteriaceae. In addition, we previously
reported that CenAsiaIII S. sonnei harbours a novel recombinant
colicin plasmid (pSSE3)11. Through genomic comparison and
Bayesian phylogenetic inference, we confirmed that this plasmid
has been stably maintained in this clade since its introduction
around the year 1995, concurrent with the first gyrA S83L
mutation (Supplementary Fig. 1). Plasmid pSSE3 likely grants
CenAsiaIII S. sonnei a competitive advantage over other Shigella
and E. coli through colicin-mediated killing activity14. Further-
more, various clusters of different colicin families (colE2, colE4,
colE5, colE8, colIa, colIb, colJs, colK, and colD) have been
sporadically acquired across the phylogeny, with colIa and colIb
integrated into the co-transferred IncI1 plasmid backbones on at
least 13 occasions (Supplementary Fig. 1). These data show that
maintenance and enrichment of colicin clusters may also facilitate
S. sonnei in forming a successful clonal expansion.
Reductive evolution in CenAsiaIII S. sonnei. Reductive evolu-
tion has played an important role in shaping the long-term
evolution of Shigella15. However, this phenomenon has not been
sufficiently studied in a rapidly emerging population. Under-
standing gene loss and pseudogenization may provide insight into
the evolutionary trajectory of this CenAsiaIII clade. We selected
one isolate (2012–02037; highlighted in Fig. 1) for long-read
Nanopore sequencing and complete genome assembly to aid in
the detection of pseudogenes arising from IS disruptions (See
Methods). Our analyses identified a total of 27 pseudogenization
events stably inherited across the phylogeny (9 IS disruptions and
18 by other mechanisms; Supplementary Table 1). Specifically,
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Fig. 3 Phylogeographical inference of CenAsiaIII Shigella sonnei. Stochastic mapping was used to estimate a the number of transitions between different
geographical states: Africa, Southeast/East Asia, Europe, and South Asia, with transitions between states that are less than one considered non-significant
and not represented in the plot, and b the proportion of time spent in each geographical state. In both panels, boxplots summarise results of 966 successful
subsamplings of the phylogeny described in Fig. 1, and stochastic mapping was performed for each with 100 simulations
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the S. sonnei population had accumulated 14 pseudogenes prior
to the formation of CenAsiaIII. Since the emergence of Cen-
AsiaIII in the late 1980s, 13 additional lineage-defining pseudo-
genizations have arisen (Fig. 2). All of these mutations were
located in genes encoding transporters (araH, arabinose; ycbO,
aliphatic sulfonate; and other substrate nonspecific transporters
yjcR, phoE, and yddA) and oxidation-reduction processes (ydhV,
ybeQ, mdaA, and ybdR). Additionally, we identified an inactiva-
tion in nfsA, which has been described to confer resistance to
nitrofurans16. Additional observed mutations potentially disrupt
metabolic pathways, such as glucuronate (uxaC) and citrate (citF)
metabolism. A truncation in yeaK, encoding a deacylase capable
of correcting tRNAs mischarged with serine/threonine (ProXp-
ST1), has been shown to negatively impact translation fidelity17.
However, tolerable levels of mistranslation have been shown to
increase fitness in E. coli subjected to oxidative stress18.
The most distinguishing mutation was the obliteration of the
flagellin monomer and its transcriptional unit, fliCAZY; we
speculate this occurred in a stepwise fashion, beginning with the
insertion of an IS630 element into fliC at a specific target
sequence (5′-CTAG-3′) prior to the divergence of CenAsiaIII19.
This IS element, in combination with an IS630 present down-
stream of fliY, may act as an excision hotspot, leading to the
deletion of the entire operon. Pan-genome analysis demonstrated
that deletion of this region has occurred on multiple occasions,
including one occurring prior to the formation of the FQr
population (Pop2) in 2005. The fliC gene encodes flagellin, a
highly immunogenic protein and the monomer for flagellum
assembly, while fliA encodes for the flagellum-specific sigma
factor (Eσ28). Though S. sonnei is conventionally non-motile,
flagellum production has been observed, albeit at a low
magnitude compared to other Enterobacteriaceae20. The removal
of the entire fliCAZY operon leads to irreversible loss of the whole
flagellar assembly. This observation further explains the subse-
quent inactivation of the redundant flagellar synthesis master
regulator, flhC, in a Bhutanese S. sonnei subclone (Fig. 2).
Furthermore, the loss of fliA in E. coli led to better survival during
stress via increased energy conservation and physical membrane
stabilisation, which resulted from the loss of the motor proteins
and the flagellum apparatus21. A previous study also found that
non-flagellated P. putida possesses greater endurance under
oxidative stress due to the release of more energy and NADPH,
which is otherwise coupled to the flagellar machinery22.
Mutation analysis of CenAsiaIII S. sonnei. Recurrent mutations
in the same gene in differing organisms serve as a hallmark of
convergent evolution, which may highlight a common adaptive
strategy to a specific selective pressure23. We aimed to detect
potential signals of convergent evolution by examining the inci-
dence of both pseudogenization and missense mutations occur-
ring within the evolutionary history of CenAsiaIII. Our analysis
revealed that rpoS is the most frequent target for inactivation (46
occasions) and missense mutations (23 occasions). However, such
mutations in rpoS may also be laboratory artefacts due to long-
term storage24. Other genes that showed evidence of convergent
pseudogenization included pepT (14 occasions), ynfK (8 occa-
sions), and puuD (7 occasions) (Supplementary Table 2). Notably,
pepT encodes a tripeptidase, which is critical for the degradation
of glutathione, a principal buffer for oxidative stress25. Conse-
quently, the inactivation of this gene increases cellular glutathione
concentration, potentially granting these organisms a higher
redox capability. Similarly, puuD encodes an intermediate
enzyme responsible for the conversion of putrescine into GABA.
Inactivation of puuD, combined with the pre-existing puuE
pseudogene, can preferentially reroute putrescine to the produc-
tion of spermidine, which scavenges free radicals and heightens
resistance to oxidative stress26. Alternatively, ynfK encodes a
putative dethiobiotin synthetase, catalysing the penultimate step
in biotin biosynthesis. We did not, however, observe inactivating
mutations in its paralogue bioD, implying that biotin biosynthesis
is more likely to be downregulated rather than inactivated. In E.
coli/Shigella, biotin acts as the key co-factor for the acyl-CoA
carboxylases (ACCs) to convert acetyl-CoA into fatty acid. Upon
host cell invasion, Shigella imports fatty acids from the host
cytosol. Therefore, depletion in biotin may direct Shigella’s acetyl-
CoA pool away from fatty acid production and conserve it for
energy generation via the conversion of acetyl-CoA into acetate27.
These examples show that though the aforementioned mutations
are not fixed in the population, their multiple independent
occurrences may provide a transient fitness advantage, thus
enhancing the progression of infection within a human host.
Selection analysis identified genes with a high density of non-
synonymous mutations, which is a measure of possible positive
selection. Among the 3637 S. sonnei homologues examined, 14
genes were predicted to have undergone positive selection
(adjusted dN/dS ranging from 1.8 to 3.6) (Table 2). Six of these
candidate genes were antimicrobial targets (gyrA and parC) or
Table 2 Genes predicted to be under selection in the CenAsiaIII Shigella sonnei population
Gene No. of Na SNPs No. of Sb SNPs Adjusted dN/dS Product GOc process
mreB 10 0 Inf Dynamic cytoskeleton protein Regulation of cell shape
gyrA 8 0 Inf DNA gyrase subunit A Response to antibiotic
putA 8 1 3.557 Proline dehydrogenase Response to oxidative stress
sigA 7 0 Inf Serine protease NA
ygjU 6 0 Inf Serine/threonine symporter Amino acid transport
ylbE 5 0 Inf Hypothetical protein NA
ynfK 5 0 Inf Dethiobiotin synthetase Biotin biosynthesis
ubiH 5 0 Inf 2-octaprenyl-6-methoxyphenol
hydroxylase
Ubiquinone biosynthesis; response to
oxidative stress
parC 5 0 Inf DNA topoisomerase IV subunit A Response to antibiotic
yahG 5 1 2.22 Membrane NA
yieO 5 1 2.223 Putative transport protein MFSd Transmembrane transport
SSON1290 4 1 1.778 Hypothetical protein NA
ydbK 4 1 1.778 Pyruvate flavodoxin oxidoreductase Response to oxidative stress
hyfB 4 1 1.778 Hydrogenase 4, component B Oxidation-reduction
aNon-synonymous single-nucleotide polymorphisms
bSynonymous single-nucleotide polymorphisms
cGene ontology biological process, as defined in EcoCyc for Escherichia coli K-12 MG1655
dMajor facilitator superfamily
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mediators of cellular oxidation-reduction processes (putA, ubiH,
ydbK, and hyfB). Several of these genes (mreB, gyrA, ubiH, and
hyf) were previously identified as undergoing diversifying
selection in the resident Vietnamese S. sonnei Global III
population12, confirming that adaptation to oxidative stress is a
common adaptive strategy for this pathogen. Notably, ynfK,
which was found to be regularly inactivated, may also be under
selection, demonstrating that partial cessation of biotin biosynth-
esis is favoured by S. sonnei.
Experimental evolution reveals differential mutational profiles
between FQr and FQs S. sonnei. Our recent diarrhoeal surveil-
lance study performed in HCMC, Vietnam during 2014–2016
found that CenAsiaIII FQr S. sonnei has gradually replaced the
resident FQs Vietnamese S. sonnei population28. We conducted
an in vitro evolution experiment aiming to identify differing
mutational profiles in these two distinct lineages upon exposure
to (fluoro)quinolones. A summary of the mutations arising dur-
ing this experiment are described in Table 3. For the
ciprofloxacin-susceptible strain cipS-VN (gyrA-S83L; Global III),
exposure to either nalidixic acid or ciprofloxacin for ~450
generations increased the MIC against both nalidixic acid
(>256 μg/mL) and ciprofloxacin. The endpoint MICs for cipro-
floxacin varied between experimental conditions and replicates,
but did not reach the defined breakpoint for resistance (1 μg/mL)
(Table 3). Exposure to nalidixic acid in cipS-VN consistently led
to disruptive mutations in the transcriptional repressor, emrR.
Such mutations are known to result in overexpression of the
EmrAB pump, also heightening resistance to nalidixic acid29.
Other explanatory mutations included a SNP in parE and a dis-
ruptive mutation in acrR. Mutations in parE were commonly
identified when cipS-VN organisms were exposed to cipro-
floxacin, either as a non-synonymous SNP or a deletion stably
inherited in both replicate populations. In addition, exposure to
ciprofloxacin, but not nalidixic acid, triggered a stable and specific
genomic deletion (treF-yhjA-yhi-hde-slp-iucABCD-iutA). This
region spans genes encoding cytochrome C peroxidase (yhjA),
acid stress resistance (yhi and hde loci), and aerobactin bio-
synthesis (iuc biosynthesis locus and iutA receptor). This region
in S. sonnei is flanked by an IS4 transposase, which may explain
the mechanism of genomic deletion. It has been recently pro-
posed that bactericidal antimicrobials, including fluor-
oquinolones, can induce cell death via the production of reactive
oxygen species (ROS)30. The common penultimate step in this
process is the stimulation of the Fenton reaction, which recruits
hydrogen peroxide and ferrous ions to produce highly cytotoxic
hydroxyl radicals. Consequently, high concentrations of intra-
cellular iron facilitate rapid FQ-mediated killing. Our data suggest
that the cipS-VN S. sonnei circumvents this by lowering intra-
cellular iron via the obliteration of the aerobactin siderophore.
Additionally, mutations targeting cysE were consistently observed
across all culture conditions for cipS-VN, but not for cipR-VN.
cysE encodes a serine acetyltransferase, catalysing the conversion
of L-serine to the O-acetyl-L-serine (OAS) quorum sensing sig-
nal. Previous studies have reported that cysE mutants exhibit an
improved capacity for in vitro biofilm formation through the
suppression of OAS production31. Additionally, minimal med-
ium, as implemented here, is known to induce biofilm formation
in E. coli32. Therefore, consistent cysE mutations may be a general
response to selective growth in minimal medium.
Exposure of cipR-VN (gyrA-S83L, parC-S80I, and gyrA-D87G;
CenAsiaIII) to nalidixic acid similarly led to enrichment of emrR
mutants, which in one case was associated with an elevated MIC
to ciprofloxacin from 8 to 12 μg/mL. Long-term exposure to
ciprofloxacin doubled the MIC to ≥16 μg/mL, and both
experimental replicates (CIP-A and CIP-B) showed mutations
in rob. The rob gene encodes the transcription activator Rob, a
Table 3 Results of antimicrobial susceptibility and mutation analysis of experimental evolution in Shigella sonnei
Conditiona MIC-CIP
(μg/mL)
MIC-NAL
(μg/mL)
Resistance
mutations
Other mutationsd Genomic deletion
cipS-VN: D0b 0.25 64 (sat)
cipS-VN: M9-A 0.19 64 (sat) cysE (P252S)
cipS-VN: M9-B 0.25 64 (sat) cysE (P252T); clpA (T374I); metJ (D76N, A61E);
rpoS (Q161P)
cipS-VN: NAL-A 0.5 >256 emrRc (fs); parE
(P571S)
cysE (A33E); cysE (S249R); cysB (P145L)
cipS-VN: NAL-B 0.38 >256 acrR (fs); emrR (fs) cysE (Q228K); dinG (fs, 2 a.a deletion); metJ
(R78P, A13T)
cipS-VN: CIP-A 0.38 >256 parE (S458L) cysE (fs); cysE (P252T) treF-yhjA-yhi-hde-slp-
iucABCD-iutA
cipS-VN: CIP-B 0.75 >256 parE (2 a.a insertion) cysE (M256I) treF-yhjA-yhi-hde-slp-
iucABCD-iutA
cipR-VN: D0 8 >256
cipR-VN: M9-A 8 NA rpoS (R277L); iucA (stop codon)
cipR-VN: M9-B 6 NA rpoS (R301H); iucD (L113P); ycjC (P47S);
SSON_2732 (2 a.a insertion)
cipR-VN: NAL-A 12 NA emrR (fs) SSON_1790 (stop codon); hemX (fs)
cipR-VN: NAL-B 8 NA emrR (I27 deletion) SSON_2588 (A93T)
cipR-VN: CIP-A 16 (sat) NA rob (G245R) eutQ (fs)
cipR-VN: CIP-B 16 (sat) NA rob (Q194K)
emrR (fs)
SSON_1804 (N200K)
fs frameshift mutation
aIn all conditions, selected strains were cultured in minimal M9 medium supplemented with glucose and niacin (25 μg/mL) with the addition of: (1) M9-A/B: no antimicrobial, (2) NAL-A/B: the same
concentration of nalidixic acid (256 μg/mL). (3) CIP-A/B: ciprofloxacin in concentrations of half the corresponding MIC of the respective strain (0.125 μg/mL for cipS-VN and 4 μg/mL for cipR-VN).
cipS-VN indicates the use of a ciprofloxacin-sensitive S. sonnei (gyrA-S83L; Global III clade) strain and cipR-VN indicates the use of a ciprofloxacin-resistant S. sonnei (gyrA-S83L, gyrA-D87G and parC-
S80I; CenAsiaIII clade) strain. (sat): satellite colonies grown inside the zone of inhibition.
bD0: initial condition on day 0.
cMutations in bold indicate those that appear to be fixed in the examined population.
dExcluding synonymous mutations, and mutations found in intergenic regions and repetitive genetic elements.
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protein composed of two functional domains. The N-terminal
domain shares substantial amino acid homology to SoxS
(responsive to oxidative stress) and MarA (responsive to
antimicrobials), indicating that the Rob regulon overlaps with
those defined for these two common regulators33. It has been
proposed that the C-terminal domain represses the activity of
Rob by sequestration, impeding its access to the transcriptional
machinery34. In our experiment, both missense mutations
observed in rob fell into its C-terminal coding region, potentially
changing its conformation and releasing more active Rob.
Overexpression of Rob is associated with resistance to multiple
antimicrobials, including quinolones35, owing to its increased
activation of multi-drug efflux pumps (directly or indirectly via
marRAB) and decreased expression of the outer membrane porin,
ompF (via upregulated micF)36,37. Our examination on the muta-
tional profiles of 395 CenAsiaIII S. sonnei revealed that there was
only one non-synonymous mutation in emrR and no mutation in
rob. In the absence of antimicrobials, cipR-VN maintained fixed
mutations in rpoS, both of which fell into the defined DNA
binding residues of sigma38 (EσS)’s domains 4.1 (R277L) and 4.2
(R301H)38. This region mediates EσS binding to the −35
promoter region of regulated genes. However, most promoters
recognised by EσS show poor conservation in the −35 element,
and mutagenesis of EσS domain 4 shows an insubstantial effect on
promoter binding strength and specificity39,40.
Discussion
The large and diverse collection utilised in this study enhanced
our capacity to investigate the origins and international dis-
semination of FQr S. sonnei. We confirmed that global FQr S.
sonnei are clonal and likely emerged in South Asia around early
2007. This finding is in agreement with a wealth of epidemiolo-
gical data citing the rise of FQr S. sonnei since 20079. It is notable
that the second and third mutations (parC-S80I, gyrA-D87G)
were acquired rapidly in the last two decades, coinciding with a
sharp increase in the use of FQ during this period, when these
drugs became routinely prescribed for shigellosis6,41. We provide
evidence of FQr S. sonnei’s sustained circulation in Southeast Asia
and Europe, but the extent of its propagation is likely to be
underestimated in regions with limited representation in our
analysis, such as East Asia, Africa, and the Americas. Indeed, the
same clone was confirmed to have caused a recent (2015) out-
break in California42. Furthermore, FQr S. sonnei harbouring
identical QRDR mutations are prevalent among the community
of men who have sex with men (MSM) in Taiwan43. These
outbreaks suggest that the organism is spreading rapidly world-
wide and poses a significant threat to public health. Transmission
within the MSM network should be closely monitored, especially
in the wake of increased shigellosis incidence and antimicrobial
resistance within this high-risk group44–46. Although we report
here that the major resistance clone has accumulated triple
QRDR mutations, we could not exclude the existence of other
resistance mechanisms. A year-long surveillance study of S. son-
nei in England and Wales identified seven FQr organisms with
the combinatorial mutations gyrA-S83L, parC-S80I, and gyrA-
D87N, which are identical to a single resistant isolate in our
collection47. Resistance due to a synergy of the PMQR gene qnrB
and gyrA mutations has also been noted in India48. The frequent
gains of resistance determinants to other first-line treatments,
ESBL and mphA, further exacerbate the problem. This issue is
emphasised in Southeast Asia, where the gene pool of the local
Enterobacteriaceae is likely to be vast and serves as a substantial
reservoir of resistance genes. We surmise that the propagation of
acquired resistance elements is likely to be underrepresented in
Europe and South Asia, as these organisms were not sourced
during active surveillance. Indeed, FQr S. sonnei circulating
among the MSM community in England and Australia have
recently acquired the epidemic mphA-carrying plasmid pKSR100,
demonstrating that differing antimicrobal exposures and trans-
mission dynamics in different patient groups may select for dis-
tinguished AMR patterns in this novel pathogen variant46,49.
Our genomic examination highlighted the prevalence of
reductive evolution mechanisms in CenAsiaIII S. sonnei, which
arose over a thirty-year timeframe. Although it is not possible to
fully catalogue pseudogenes generated via IS element disruptions,
we observed some noticeable evolutionary trends. These included
the disruption of several metabolic functions, specifically the
fermentative processes of alternate carbon sources, as well as the
cessation of cellular appendages such as flagella and pili. Fur-
thermore, our analysis pointed to selection for better adaptation
under oxidative stress. This is supported by the finding that most
of the genes identified to be subject to convergent evolution and
potential selection are linked to oxidation-reduction processes.
We speculate that the high pressure of oxidative stress may ori-
ginate from varied sources but is most likely due to the oxidative
environment within the macrophage or exposure to anti-
microbials such as fluoroquinolones. Improved survival during
stress could benefit FQr S. sonnei clones in their expansion into
different geographical destinations. However, this interpretation
may be subject to scrutiny given that dN/dS selection analyses are
not particularly well-suited for investigating rapidly evolving
intraspecific bacterial populations50. Specifically, the nucleotide
differences observed within a population do not represent fixed
divergences but rather transient polymorphisms, which are not
necessarily purged from the population due to the short evolu-
tionary timeframe considered in this study.
Exposure to a quinolone antimicrobial resulted in disruption of
the efflux pump repressor, EmrR, for both FQr and FQs S. sonnei
despite having different genetic backgrounds. In addition, we
showed that mutations in the Rob transcriptional activator result
in resistance to FQ at very high MIC. It is surprising that, despite
its harbouring of a gyrA mutation, continuous exposure of this
FQ-susceptible S. sonnei to ciprofloxacin failed to generate spe-
cific resistance mutations in gyrA and parC. Previous in vitro
studies have also reported that in E. coli with single gyrA muta-
tion background, mutations linked to drug efflux but not specific
QRDR targets are preferentially selected51. This finding also
corroborates the observation that indigenous Vietnamese S.
sonnei did not accumulate triple mutations to achieve FQ resis-
tance, even though fluoroquinolones are commonly used in this
setting. FQ resistance attributed to QRDR mutations has been
shown to not be associated with detrimental fitness cost in
Enterobacteriaceae in vitro, even in the absence of FQ52,53. Here
we predict that, in the absence of quinolone pressure, FQr S.
sonnei showed mutational bias toward alternating the rpoS-
induced stress response. Since the experimental evolution com-
ponent only included two replicates per strain-condition combi-
nation, a larger study may be performed to confirm whether rpoS
mutations are truly compensatory for the resistance genotype.
Though we elucidated the evolution and spread of this emer-
ging FQr S. sonnei population, the long-term clinical and public
health significance of this clone remains unclear. Our recent
observations in Vietnam demonstrated that disease severity and
recovery in S. sonnei-infected children were independent of the
organism’s ciprofloxacin susceptibility profile28. Additionally,
evolutionary trajectories and development of resistance to other
antimicrobial classes in already FQr isolates in different ecological
niches require further investigation. Future research should be
focused on the collateral issues associated with FQ and to explore
how FQr affects other patient cohorts, including the mal-
nourished, the elderly, and the immunocompromised.
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Methods
Organism collection and whole-genome sequencing. This investigation centring
on the international dissemination of FQr S. sonnei was performed by combining
WGS data from our previous investigations with an additional 265 isolates
sequenced for this study9,11. This resulted in a collection of 411 S. sonnei isolates
(Bhutan, n= 71; Vietnam, n= 24; Thailand, n= 8; Cambodia, n= 1; Ireland, n=
20; Australia, n= 85; France, n= 97; England, n= 91; global references, n= 14).
Table 1 provides a summary of the organisms used in this study; associated
metadata are detailed in Supplementary Data 1. The isolates from shigellosis
endemic countries (Bhutan, Vietnam, Thailand, Cambodia) are mostly FQr and
sourced from multiple diarrhoeal surveillance studies in the respective countries.
Institutional review board (IRB) approval and informed consent for these studies
have been described previously9. Isolates from shigellosis non-endemic regions
were collected from public health laboratories (Ireland, Australia, England, France),
and these were mostly isolated from adults with recent travel histories. These
isolates were collected from anonymous sources at local public health laboratories,
and were not subject to IRB approval, so informed consent was not required. When
available, the patients’ recent travel records were reported to identify the original
geographic sources of the infections. Isolates were selected preferentially if they
showed reduced ciprofloxacin susceptibility (intermediate to full resistance to
ciprofloxacin), or if they originated from South Asia. Susceptibility to ciprofloxacin
was determined using a variety of methods, including disk diffusion, E-test, agar
dilution, and broth microdilution, as detailed in Table 1. The breakpoint for
ciprofloxacin resistance was inferred following guidelines from the European
Committee on Antimicrobial Susceptibility Testing (http://www.eucast.org/
clinical_breakpoints/)9. Specifically, MIC to ciprofloxacin >1 μg/mL is classified as
being resistant. For all S. sonnei isolates, genomic DNA was extracted using
commercial kits and subjected to WGS on various Illumina platforms to produce
paired-end short-read sequences (Table 1). These sequence data were then con-
solidated for analysis and interpretation.
Short read mapping and phylogenetic reconstruction. All reads were mapped to
the S. sonnei Ss046 reference sequence (accession number: NC_007384) using
SMALT (version 0.7.4). High-quality SNPs were called and filtered using SAMtools
and bcftools, removing those matching any of the following criteria: consensus
quality < 50, mapping quality < 30, ratio of SNPs to reads < 75%, read depth < 4,
and number of reads per strand < 2. We previously found that all sequenced FQr S.
sonnei clustered within the Central Asian expansion of Lineage III (CenAsiaIII
clade)9. Preliminary phylogenetic reconstruction demonstrated that among 411
examined sequences, only eleven were not of the CenAsiaIII clade. These eleven
sequences, together with another two sequences with poor mapping quality and
three most closely related sequences as outgroups to the CenAsiaIII clade, were
removed to create a final set of 395 sequences belonging to this clade and utilised in
downstream analyses. Regions attributed to recombination were detected using
Gubbins54. These recombinogenic elements were removed, alongside previously
determined mobile genetic elements, invariant sites, and columns with at least 2%
indeterminate bases, to create a final alignment of 3,980 SNPs across 396 taxa (395
CenAsiaIII and one closely related outgroup). Maximum-likelihood phylogenies
were constructed in five separate runs using RAxML v8.1.3 under the GTRCAT
model, with sufficient bootstrap replicates automatically determined by the
extended majority rule (MRE) bootstrap convergence55. Trees were visualised in
association with metadata using the web-based interactive Tree of Life (iTOL)56.
Hierarchical Bayesian clustering for population structure. Phylogeny-
independent hierarchical Bayesian clustering (hierBAPS) was applied to the above
alignment to assess population structure within the 395 CenAsiaIII isolates57,58.
This was performed in ten independent analyses, with three layers of sub-clustering
and the maximum number of clusters ranging from 10 to 40. These analyses
identified two populations of identical membership in 8/10 instances, with all FQr
S. sonnei belonging to a single population (named Pop2); all FQs belong to Pop1.
Bayesian phylogenetic inference. Aiming to examine the temporal structure of
the CenAsiaIII clade, we subsampled to include 144 sequences (72 from each
hierBAPS determined population, with a maximum of five isolates per calendar
year in each geographic region). This subsampling generated an alignment of 2448
recombination-free SNPs, and a maximum-likelihood phylogeny was inferred as
described above. A TVM (transversion) model of nucleotide substitution was
determined to be the most appropriate for this alignment, using the fast Mod-
elFinder implemented in IQ-TREE v1.6.759,60. Path-O-Gen (v1.4) was used to
assess the linearity of the relationship between root-to-tip divergence and sampling
date (in month/year; R2= 0.845), and BEAST v.1.8.3 was used to estimate the
substitution rate and time to the most recent common ancestor (tMRCA) of the
CenAsiaIII clade61. To identify the best-fit model for the dataset, multiple BEAST
runs were conducted utilizing combinations of the TVM+ Γ4 substitution model,
strict or relaxed lognormal clock models, and constant or Bayesian skyline
demographic models. Each of these analyses was performed in triplicate using a
continuous 200 million generation MCMC chain with samples taken every 20,000
generations. Parameter convergence was assessed visually in Tracer v1.5 (ESS >
200). For robust model selection, both path sampling and stepping-stone sampling
approaches were applied to each BEAST analysis to estimate the marginal
likelihood62,63. The best model selected by Bayes factor comparison was a strict
molecular clock with a piecewise Bayesian skyline demographic model. For this
model, triplicate runs were combined using LogCombiner v1.8.3, with removal of
20% burn-in. We additionally repeated the same procedure for 141 selected Pop2 S.
sonnei to estimate the divergence time of the FQr clone. These analyses again
indicated that the TVM+ Γ4 substitution model with a strict clock and Bayesian
skyline demographic model was the best fit to the data. We selected a subset of 134
exclusively FQr S. sonnei (all containing gyrA S83L, parC S80I, and gyrA D87G) to
infer the population dynamics of the clone since its emergence to avoid artificial
interpretation of population expansion created by mixing multiple subpopula-
tions64. BEAST runs were performed in triplicate and conducted using the TVM+
Γ4 substitution model, a strict molecular clock with the constant, Bayesian skyline,
skygrid, or skyride demographic model65,66. The best-fit of these demographic
models was the Bayesian skyline model.
Phylogeographical analysis of CenAsiaIII S. sonnei. The reference-based max-
imum likelihood phylogeny of 395 CenAsiaIII S. sonnei served as an input for
reconstructing the ancestral geographical states of each isolate, as adopted from a
recently described approach67. We treated geographical source (sub-continental
level) of the organisms as discrete characters. Due to biased sampling toward South
Asia, we subsampled the phylogeny to include equal numbers of isolates from each
character state (i.e. geographical region; n= 13 from South Asia, Africa, Europe,
and combined Southeast Asia/East Asia), generating 1000 subsampled trees.
Regions with fewer than 13 isolates (i.e. Middle East and America) were excluded.
We utilised stochastic mapping to quantify transition events between geographical
characters as well as the total time spent within each character state, separately for
each subsampled tree68. Stochastic mapping, implemented using the function
make.simmap in the R package phytools v0.6.0, was performed under an asym-
metric model of character change (ARD) with the rate matrix sampled from the
posterior probability distribution using MCMC (Q=mcmc) for 100 simulations69.
To ensure that resultant phylogeographical signal was not an artefact due to
oversampling in South Asia, we permuted (without replacement) the tip-location of
the original maximum likelihood phylogeny, generating ten independent rando-
misation sets. We repeated stochastic mapping analysis for each randomisation as
detailed above, using only 500 subsampled trees from each randomisation to
reduce computational expense. Results from the ‘true’ and ‘randomisation’ runs
were compared by analysis of variance (ANOVA) with post-hoc Tukey test.
Determination of the accessory genome. We performed a de novo sequence
assembly using Velvet v1.2.03 and VelvetOptimizer for each isolate, and each read
set was mapped back to the corresponding assembly70. Contigs with size <300 bp
were eliminated, and annotation was determined for each assembly using Prokka71.
ARIBA, a platform to detect genetic elements of choice from short reads, was
deployed to detect the presence of antimicrobial resistance (AMR) genes, plasmid
incompatibility types, and colicin types based on the reliably curated ResFinder,
PlasmidFinder, and an in-house colicin database, respectively72–74. To identify
contigs associated with the accessory genome, the assembly of each organism was
ordered with reference sequences of Ss046 and the virulence plasmid (pSS046)
using ABACAS. Contigs identified to belong to plasmids were queried against the
public nucleotide databases using BLASTN. Artemis and Artemis Comparison
Tool (ACT) were used to visualise the presence of specific genetic elements in the
isolates75.
Detection of pseudogenes and gene loss. Pseudogenes can be formed by
numerous mechanisms in Shigella, including gene deletion, gene disruption by
insertion sequences (IS) or small indels, and substitutions leading to gain of stop
codons or loss of start codons. We selected an FQr CenAsiaIII isolate for long-read
Nanopore sequencing (sample 2012–02037) to produce a high-quality complete
reference for identification of potential pseudogenes. We compared the entire
genome sequence of 2012–02037 to Ss046 reference using ACT to identify regions
pertaining to genomic deletions or disrupted by IS elements, but discounting such
events that occurred within IS elements. In total, we detected sixteen candidate
events, including two genomic deletions (aadA2 and fliCAZY) and 14 IS disrup-
tions. The pan-genome of 395 CenAsiaIII S. sonnei sequences was then constructed
using Roary with default setup76, and gene losses were queried in all 395 isolates to
record their presence/absence within the genome sequences. For the 14 IS dis-
ruption events, the intactness of these was queried against all CenAsiaIII strains
using ARIBA, setting the matching length cutoff to 95%. This showed that nine
such disruptions were stably inherited throughout the phylogeny (Supplementary
Table 1).
To detect pseudogenes formed by substitutions and small indels, we extracted
393 CenAsiaIII variant calling format (vcf) files (two could not be retrieved)
generated by mapping the reads to reference Ss046. Mutations were annotated with
SnpEff v4.1b using the Ss046 reference, and were retained if they passed the quality
filtering step and were classified by SnpSift v4.1b as (i) indels within genes, (ii) loss
of a start codon, or (iii) gain of a stop codon77. Identified mutations within IS and
repetitive elements were considered unreliable and removed from further analyses.
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dN/dS analysis on substitutions in CenAsiaIII S. sonnei. For the 395 CenAsiaIII
sequences, substitutions across the reference Ss046 were summarised and
annotated using SnpEff v4.1b. Point mutations present within mobile, repetitive,
or recombination elements (as defined in the ‘phylogenetic reconstruction’
section) were excluded, resulting in a set of 4230 mutations available for
examination. Due to the limited temporal sampling period, we assessed the dN/
dS ratio (non-synonymous to synonymous substitution rate) to detect potential
signals of selection, adopted from a previously recommended approach23,78. In
brief, a phylogenetic tree was constructed using these 4230 SNPs in RAxML
v8.1.3, and PAML was used for ancestral state reconstruction of all SNPs79.
Mutations were classified as intergenic, synonymous, or non-synonymous based
on comparison of each SNP to its annotation and the reconstructed ancestral
state. The dN/dS rate was adjusted for transition/transversion rate and codon
frequencies under the NY98 model80. Genes were determined to be under
positive selection if their adjusted dN/dS ratio was >1.5 or if they possessed no
synonymous and at least five non-synonymous mutations (Table 2, Supple-
mentary Table 3).
Experimental evolution. To examine how continuous exposure to FQ may impact
the evolution of S. sonnei, we selected a representative isolate from each of the FQr
(CenAsiaIII) and the FQs (GlobalIII) clades. Both isolates, cipR-VN (gyrA-S83L,
parC-S80I, and gyrA-D87G) and cipS-VN (gyrA-S83L), were isolated in 2015 as part
of a hospital-based diarrhoeal surveillance study conducted in Ho Chi Minh City,
Vietnam81. Isolates were selected based on sequencing quality and the absence of
plasmids encoding resistance to 3rd generation cephalosporins and macrolides (to
discount potential interactions). The MICs to ciprofloxacin and nalidixic acid were
reconfirmed by E-test and broth dilution. M9 minimal was used as culture medium
for the experiment to limit over-proliferation. The M9 medium was supplemented
with glucose as the sole carbon source (final concentration, 0.4%), and niacin (final
concentration, 25 μg/mL) as Shigella cannot synthesise this vitamin de novo82.
CipR-VN and cipS-VN were subjected to three longitudinal culture
conditions in duplicate: (i) M9 (glucose+ niacin) medium only, (ii) M9 (glucose
+ niacin) supplemented with 256 μg/mL of nalidixic acid, and (iii) M9 (glucose
+ niacin) supplemented with half the appropriate MIC of ciprofloxacin (0.125
μg/mL for cipS-VN and 4 μg/mL for cipR-VN). Cultures were incubated at 37 °C
with continuous agitation for eight weeks, a duration expected to be sufficient to
generate ciprofloxacin-resistant progenies from cipS-VN83; a sub-culture was
performed every 24 h by transferring 20 μL into 5 mL of fresh medium. This
process resulted in approximately eight bacterial generations (log2[5000/20]) per
24 h. At the end of the experiment (D56), organisms were harvested from 2 mL
culture from each of the twelve experiments. Total genomic DNA was extracted
from each sample using the Wizard Genomic DNA Extraction kit (Promega),
and these were predicted to represent S. sonnei population diversity within each
condition. Library preparation and deep sequencing by Illumina MiSeq (~100×
coverage) were performed for all twelve samples to generate 2 × 250 bp paired-
end reads. For each sample, reads were mapped to reference Ss046 by BWA-
MEM, and high-quality SNPs were called by SAMtools and retained if they had a
consensus quality > 50, mapping quality > 30, and read depth > 384. Analyses
were then performed independently for cipR-VN and cipS-VN, using existing
sequence data as timepoint zero (D0). The Genome Analysis Toolkit (GATK)
was employed to extract differing mutations between the paired sequences (D0
and D56), eliminating those identified in all conditions85. We additionally
confirmed the fidelity of these mutations using Artemis and ACT. De novo
assemblies were constructed for each isolate using SPAdes v3.9.086, and a pan-
genome was constructed separately for cipR-VN and cipS-VN by Roary to
identify genomic deletions.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Short-read sequence data generated for this study are available in the European
Nucleotide Archive under project ERP012925 and runs ERR586829-ERR586845,
ERR591140-ERR591218, and in the NCBI Sequence Read Archive under project
PRJNA320210. The raw sequencing reads for the in vitro evolution experiment are
available in NCBI Sequence Read Archive under project PRJNA553864. The phylogeny
and associated metadata have been uploaded to Microreact for interactive viewing
(https://microreact.org/project/ByXyXYgle). NCBI accession numbers for plasmids
detected in our isolates are included in Supplementary Data 2. The source data
underlying Fig. 3 and Supplementary Figs. 2 and 3 are available within the Source Data
file. All other data supporting the findings of this study are available in this article and its
Supplementary Information files.
Code availability
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